Product Information
FEXOFENADINE HCL 180 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.2302 per EA under NDC 68001044004. Its NADAC has been published 308 times since Nov 11, 2020.
FDA first approved this application on Apr 11, 2006.
Strength
180 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001044004
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076502FDA Approved
4/11/2006
On Market Since
6/19/2020
Pharmacological Classes
Price Statistics
The NADAC for FEXOFENADINE HCL 180 MG TABLET has been published 308 times since Nov 11, 2020, and over the history we have for it it has declined 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2302 per EA |
|---|---|
| All-time high | $0.3070 (Jun 16, 2021) |
| All-time low | $0.2079 (Nov 20, 2024) |
| 52-week high | $0.2728 |
| 52-week low | $0.2302 |
| Median price | $0.2703 |
| Average price | $0.2684 |
| Largest weekly change | -24.0% (Nov 20, 2024) |
| Weeks tracked | 308 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fexofenadine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FEXOFENADINE HCL 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEXOFENADINE HCL 180 MG TABLET, manufactured by BluePoint Laboratories, is $0.2302 per EA (NDC 68001044004), effective Sep 30, 2026.
How has the price of FEXOFENADINE HCL 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEXOFENADINE HCL 180 MG TABLET has declined 17.5%. It has been tracked across 308 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for FEXOFENADINE HCL 180 MG TABLET?
Since Nov 11, 2020, the NADAC for FEXOFENADINE HCL 180 MG TABLET has ranged from a low of $0.2079 (Nov 20, 2024) to a high of $0.3070 (Jun 16, 2021), with a median of $0.2703 per EA.
Are there cheaper alternatives to FEXOFENADINE HCL 180 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FEXOFENADINE HCL 180 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FEXOFENADINE HCL 180 MG TABLET?
FEXOFENADINE HCL 180 MG TABLET (NDC 68001044004) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.